Intrathoracic extracardiac hemangiosarcoma (HSA) is rare in dogs. This report describes three dogs with acute onset dyspnea due to hemorrhagic pleural effusion resulting from intrathoracic extracardiac masses, which were confirmed as HSA by histopathology. The dogs were stabilized with thoracocentesis and intravascular fluid resuscitation. Computed tomography identified intrathoracic masses, which were not originating from the heart or pulmonary parenchyma.
Introduction
Hemangiosarcoma (HSA) is a malignant endothelial tumor and is common in dogs. 1, 2 Canine HSA predilection sites are the spleen, right atrium, liver, and skin, although they can originate from any vascular tissue. [2] [3] [4] [5] [6] The initial treatment of choice is surgical excision of the mass. 2 However, treatment is palliative with most dogs succumbing to metastatic disease and 80% of cases having overt metastasis on presentation. 2, 7 Median survival time for splenic HSA is short, ranging from 19 to 240 days. 8, 9 In dogs with splenic HSA, administration of chemotherapy has been shown to increase survival times compared to dogs treated with splenectomy only. 1 Doxorubicin has the greatest efficacy against canine HSA.
2
The clinical presentation is dependent on HSA location, but patients often present collapsed due to hemorrhage and hypovolemia with a history of episodic collapse and lethargy. 2 A case of intrathoracic extracardiac HSA has been reported in one dog, where stabilization was not successful and the dog died. 10 This case series reports three HSA cases that presented with collapse and dyspnea due to intrathoracic haemorrhage. The hemothorax in these cases was due to intrathoracic HSA that did not originate from the heart or pulmonary parenchyma. Two of these cases survived surgical mass excision.
Case Study

Case 1
A 10 yr old male neutered golden retriever presented to the referring veterinarian with a 12 hr history of dyspnea and exercise intolerance. There was no history of trauma. Pleural effusion was diagnosed by thoracic ultrasound and 400 mL of bloody fluid was removed by needle thoracocentesis. Figure 1A ).
Iohexol ff , an iodine based contrast medium, at a dose of 2 mL/kg was administered IV. The mass had heterogenous uptake of IV contrast. The origin of the mass could not be determined.
Abdominal CT was unremarkable.
The primary differential diagnosis was a malignant vascular neoplasm, such as HSA. Exploratory thoracotomy was performed via median sternotomy. The mass was adherent to the aorta; therefore, dissection of the mass was not possible and the dog was There was an 8 cm spherical, multiple lobulated, firm, dark purple mass in the caudoventral mediastinum attached to the ventral sternum. Dorsally the mass surrounded the vena cava but was not adherent to it. The mass was circumferentially dissected from its pleural attachments using a bipolar tissue sealing device h and blunt dissection. The entire mass was removed; however, there were multiple small 1 to 2 mm dark coloured nodules throughout the pleura, adjacent and distant to the mass. the pulmonary parenchyma or pleura were present making surgical excision of the mass feasible, although a midline sternotomy from the xiphoid to the level of the fifth sternebrae was necessary to improve exposure. The mass was not cut into using this approach, but an ostectomy of the xiphisternum and sixth sternebrae was necessary as they were firmly attached to the broad base of the mass. An oscillating saw l was used for removal of the sternebrae.
The intercostal vessels and any aberrant vasculature to the mass were ligated. A right-sided silicone thoracic drain i was placed in the 
Discussion
This case series reports three dogs that presented acutely with dyspnea caused by hemothorax. All of the cases had advanced imaging using CT and had attempted surgical resection of the intrathoracic masses.
CT scans were used to fully stage all dogs and revealed intrathoracic masses with similar contrast-enhancing heterogeneous appearances. Thoracic radiographs or thoracic ultrasonography were performed by the referring vets, which had demonstrated pleural effusion. We elected to preform advanced imaging by CT in all cases rather than repeating radiography. 13 The differential diagnoses for soft tissue attenuating cavitatary mass lesions are neoplasia, granuloma, cyst, hematoma, and abscess. The origin of the masses and possible organ invasion could not be determined on CT scan. This was highlighted in case 2 where the mass appeared to envelop the caudal vena cava on CT but was not adherent to it at surgery. This is in agreement with a retrospective study that found that CT had a low sensitivity for predicating vascular invasion of mediastinal masses and highlighted the shortcomings in using CT for decision making preoperatively. 12, 13 It is important to emphasize that surgical exploration was required to determine if the intrathoracic masses were indeed resectable and even this small case series has shown that CT, although helpful for intraoperative planning, cannot definitively be used to determine if a mass is resectable.
The cases reported in this series are novel in the veterinary literature, as they were intrathoracic but not cardiac in origin.
HSA commonly affects visceral organs, namely the spleen, liver, and right auricular appendage. 7, 13, 14 Patients with cardiac HSA often present with cardiac tamponade due to hemorrhagic pericardial effusion. Surgical resection of the mass, if possible, is the initial treatment of choice. 7, 13, 14 A case of periaortic HSA has been reported; the dog in this report died before surgical exploration was attempted. 10 We felt that our case series is an important addition to the veterinary literature as it documents that surgical resection with survival to discharge is possible for intrathoracic, extracardiac HSA.
Due to the high suspicion of HSA based on the CT scans, all owners were advised of the guarded long-term prognosis, but they all opted to pursue palliative surgery followed by chemotherapy.
Although obtaining a cytologic sample or tissue biopsy would have been useful in the decision making process, it would not have changed the decision to perform surgery because of the high risk of ongoing hemorrhage in these cases. Based on these cases and the current literature on HSA, surgical exploration and resection of the bleeding mass is required. [1] [2] [3] [4] [5] [6] 17 This case series has reported that it is possible for intrathoracic HSA cases to survive until discharge and that as with other locations of HSA surgical treatment is palliative. It is important to council the owners of the palliative nature of the surgery and that, as in case 1, surgical resection may not be possible.
Conclusion
Intrathoracic extra-cardiac HSA can be treated in a similar fashion to HSA in other locations with surgical hemostasis and resection of the tumor followed by adjuvant chemotherapy. We have reported three dogs that presented with acute onset dyspnea due to hemorrhagic pleural effusion from intrathoracic HSA. CT was used to demonstrate the mass but was not able to determine if the mass was surgically removable. Intrathoracic extra-cardiac HSA should be considered as a differential diagnosis for nontraumatic hemothorax and surgical treatment can be palliative. 
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